RxDoctor Payments DataLook up a doctor →

Brian Finley, MD

Family Medicine · Bellevue, NENPI 1144278482

Payments from drug & device makers

$20,381in general payments, 2019–2025

Across 877 payments — averaging $23.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$4K
  • AstraZeneca$2K
  • Lilly USA, LLC$2K
  • Amgen$1K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
  • Novo Nordisk$935
  • plus $9K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)191$4,083
AstraZeneca51$2,337
Lilly USA, LLC91$1,535
Amgen40$1,200
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)40$1,077
Novo Nordisk52$935
Bayer34$901
Otsuka America Pharmaceutical, Inc.45$852
Johnson & Johnson26$732
Pfizer38$626
Novartis31$483
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC18$448
Lundbeck LLC14$403
E.r. Squibb & Sons, L.L.C.10$363
GSK12$346
Supernus Pharmaceuticals, Inc.5$298
Vanda Pharmaceuticals Inc.7$240
Idorsia Pharmaceuticals US Inc9$209
Takeda Pharmaceuticals U.S.A., Inc.13$196
Gilead4$188
Astellas Pharma US Inc5$182
Biohaven Pharmaceuticals, Inc.3$163
Ardelyx, Inc.5$156
Teva Pharmaceuticals USA, Inc.2$138
Lexicon Pharmaceuticals, Inc.2$133
Jazz Pharmaceuticals Inc.9$130
Merck9$130
Collegium Pharmaceutical, Inc.14$122
Axsome Therapeutics, Inc.6$116
Boehringer Ingelheim7$111
Biohaven Pharmaceutical Holding Company Ltd.6$107
Avanir Pharmaceuticals, Inc.8$103
Eisai Inc.6$102
Aimmune Therapeutics, Inc.1$82
Nestle Healthcare Nutrition Inc.4$80
Acadia Pharmaceuticals Inc4$72
Sumitomo Pharma America, Inc.4$72
Sanofi Pasteur Inc.2$68
Alkermes, Inc.3$58
Paratek Pharmaceuticals, Inc.2$44
Sanofi-aventis U.S. LLC2$44
Optinose US, Inc.1$39
Abiomed1$35
Azurity Pharmaceuticals, Inc.2$35
Almatica Pharma LLC2$34
Indivior Inc.2$34
Sunovion Pharmaceuticals Inc.5$33
Verona Pharma, Inc.1$31
Biogen2$31
Exact Sciences2$31
Boston Scientific1$30
Kowa Pharmaceuticals America, Inc.2$30
Tolmar, Inc.2$29
Vertical Pharmaceuticals, LLC2$28
Inspire Medical Systems, Inc.1$27
Mallinckrodt Hospital Products Inc.1$22
Ironshore Pharmaceuticals Inc.1$20
Evoke Pharma, Inc.1$20
Ultragenyx Pharmaceutical Inc.1$19
Scilex Pharmaceuticals Inc.1$19

How this compares

$20,381 in reported general payments places this provider in the 95th percentile of 981 family medicine providers in Nebraska.

See all family medicine providers in Nebraska →

Medicare billing

Part B allowed, 2024
$180,187
Medicare patients
353
Services billed
3,476

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Bellevue

See the full list for Nebraska →

Where these figures come from

Is this you, or does something look wrong? →